Literature DB >> 30829727

PGR Gene Fusions Identify a Molecular Subset of Uterine Epithelioid Leiomyosarcoma With Rhabdoid Features.

Sarah Chiang1, Wesley Samore2, Lei Zhang1, Yun-Shao Sung1, Gulisa Turashvili3, Rajmohan Murali1, Robert A Soslow1, Martee L Hensley4, David Swanson3, Brendan C Dickson3, Colin J R Stewart5, Esther Oliva2, Cristina R Antonescu1.   

Abstract

Genetic aberrations among uterine epithelioid leiomyosarcomas are unknown. Following identification of an index case with NR4A3-PGR fusion demonstrating monomorphic morphologic features, we interrogated additional uterine tumors demonstrating similar histology and sought to describe the morphologic and immunohistochemical characteristics of PGR-rearranged sarcomas. Targeted next-generation RNA sequencing was performed on RNA extracted from formalin-fixed paraffin-embedded tissue of the index case. Fluorescence in situ hybridization using custom probes flanking PGR and NR4A3 genes was applied to 17 epithelioid leiomyosarcomas, 6 endometrial stromal tumors, and 3 perivascular epithelioid cell tumors. NR4A3-PGR fusion (n=4) and PGR rearrangement (n=2) were detected in 6 (35%) epithelioid leiomyosarcomas. Median patient age was 45 years, and all presented with FIGO stage I or II tumors, 2 being alive with disease at 75 and 180 months. All tumors were centered in the cervical stroma or myometrium and consisted of cells with abundant eosinophilic cytoplasm (epithelioid), including many displaying dense intracytoplasmic inclusions (rhabdoid). Myxoid matrix and hydropic change imparted a microcystic growth pattern in 4 tumors. Five also showed a minor spindle cell component which was low-grade in 3, consisting of bland spindle cells with low mitotic activity. High-grade spindle cell morphology was seen in 2 tumors, exhibiting a storiform pattern of atypical spindle cells associated with brisk mitotic activity. Desmin, estrogen receptor, and progesterone receptor were positive in all 6 tumors, while CD10 and HMB45 were negative. PGR rearrangements define a genetic subset of epithelioid leiomyosarcomas with often biphasic morphology consisting of epithelioid and rhabdoid as well as spindle cell components.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30829727      PMCID: PMC6520111          DOI: 10.1097/PAS.0000000000001239

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  46 in total

1.  Epithelioid smooth-muscle tumors of the uterus: a clinicopathologic study of 18 patients.

Authors:  R A Prayson; J R Goldblum; W R Hart
Journal:  Am J Surg Pathol       Date:  1997-04       Impact factor: 6.394

2.  HMB45+ cells in mixed stromal-smooth muscle tumour of the uterus.

Authors:  M Zamecnik; L Voltr; A Chlumska
Journal:  Histopathology       Date:  2006-03       Impact factor: 5.087

3.  Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.

Authors:  Lien N Hoang; Amandeep Aneja; Niamh Conlon; Deborah F Delair; Sumit Middha; Ryma Benayed; Martee L Hensley; Kay J Park; Travis J Hollmann; Meera R Hameed; Cristina R Antonescu; Robert A Soslow; Sarah Chiang
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

4.  BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.

Authors:  Adrián Mariño-Enriquez; Alexandra Lauria; Joanna Przybyl; Tony L Ng; Magdalena Kowalewska; Maria Debiec-Rychter; Raji Ganesan; Vaiyapuri Sumathi; Suzanne George; W Glenn McCluggage; Marisa R Nucci; Cheng-Han Lee; Jonathan A Fletcher
Journal:  Am J Surg Pathol       Date:  2018-03       Impact factor: 6.394

5.  Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.

Authors:  Alexander Drilon; Theodore W Laetsch; Shivaani Kummar; Steven G DuBois; Ulrik N Lassen; George D Demetri; Michael Nathenson; Robert C Doebele; Anna F Farago; Alberto S Pappo; Brian Turpin; Afshin Dowlati; Marcia S Brose; Leo Mascarenhas; Noah Federman; Jordan Berlin; Wafik S El-Deiry; Christina Baik; John Deeken; Valentina Boni; Ramamoorthy Nagasubramanian; Matthew Taylor; Erin R Rudzinski; Funda Meric-Bernstam; Davendra P S Sohal; Patrick C Ma; Luis E Raez; Jaclyn F Hechtman; Ryma Benayed; Marc Ladanyi; Brian B Tuch; Kevin Ebata; Scott Cruickshank; Nora C Ku; Michael C Cox; Douglas S Hawkins; David S Hong; David M Hyman
Journal:  N Engl J Med       Date:  2018-02-22       Impact factor: 91.245

6.  High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.

Authors:  Andrew P Sciallis; Patrick P Bedroske; John K Schoolmeester; William R Sukov; Gary L Keeney; Jennelle C Hodge; Debra A Bell
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

7.  ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus.

Authors:  Nissreen Mohammad; Josh D Haimes; Skyler Mishkin; Brian A Kudlow; May Ying Leong; Sung Hock Chew; Eleanor Koay; Ann Whitehouse; Nichola Cope; Rola H Ali; Martin Köbel; Colin J R Stewart; W Glenn McCluggage; Cheng-Han Lee
Journal:  Am J Surg Pathol       Date:  2018-10       Impact factor: 6.394

8.  Dramatic response to alectinib in inflammatory myofibroblastic tumor with anaplastic lymphoma kinase fusion gene.

Authors:  Masafumi Saiki; Fumiyoshi Ohyanagi; Ryo Ariyasu; Junji Koyama; Tomoaki Sonoda; Shingo Nishikawa; Satoru Kitazono; Noriko Yanagitani; Atsushi Horiike; Hironori Ninomiya; Yuichi Ishikawa; Makoto Nishio
Journal:  Jpn J Clin Oncol       Date:  2017-12-01       Impact factor: 3.019

9.  Integrated genomic analyses of ovarian carcinoma.

Authors: 
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

10.  Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required.

Authors:  Justine L Pickett; Angela Chou; Juliana A Andrici; Adele Clarkson; Loretta Sioson; Amy Sheen; Jessica Reagh; Fedaa Najdawi; Yoomee Kim; Denise Riley; Jayne Maidens; David Nevell; Kirsten McIlroy; Susan Valmadre; Greg Gard; Russell Hogg; John Turchini; Gregory Robertson; Michael Friedlander; Anthony J Gill
Journal:  Am J Surg Pathol       Date:  2017-10       Impact factor: 6.394

View more
  4 in total

1.  Recurrent KAT6B/A::KANSL1 Fusions Characterize a Potentially Aggressive Uterine Sarcoma Morphologically Overlapping With Low-grade Endometrial Stromal Sarcoma.

Authors:  Abbas Agaimy; Blaise A Clarke; David L Kolin; Cheng-Han Lee; Jen-Chieh Lee; W Glenn McCluggage; Patrik Pöschke; Robert Stoehr; David Swanson; Gulisa Turashvili; Matthias W Beckmann; Arndt Hartmann; Cristina R Antonescu; Brendan C Dickson
Journal:  Am J Surg Pathol       Date:  2022-05-17       Impact factor: 6.298

2.  Study on the Multitarget Mechanism and Active Compounds of Essential Oil from Artemisia argyi Treating Pressure Injuries Based on Network Pharmacology.

Authors:  Shu-Ting Lu; Lu-Lu Tang; Ling-Han Zhou; Ying-Tao Lai; Lan-Xing Liu; Yifan Duan
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-19       Impact factor: 2.650

3.  Case Report: A case of uterine leiomyosarcoma metastasized to the vena cava, excised with the aid of preoperative CT three-dimensional imaging.

Authors:  Ling Long; Ling Zhou; Demei Ying; Yan Huang; Juan Yang; Lu Zhou; Sufen Li; Xuan He; Rongkai Xie
Journal:  Front Oncol       Date:  2022-08-16       Impact factor: 5.738

4.  Identification of Novel PGR-NR4A3 Fusion in Extraskeletal Myxoid Chondrosarcoma and Resultant Patient Benefit From Tamoxifen Therapy.

Authors:  H Catherine Wilbur; Dan R Robinson; Yi-Mi Wu; Chandan Kumar-Sinha; Arul M Chinnaiyan; Rashmi Chugh
Journal:  JCO Precis Oncol       Date:  2022-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.